Cargando…
Intravitreal Anti-vascular Endothelial Growth Factor versus Observation in Acute Central Serous Chorioretinopathy: One-year Results
PURPOSE: To evaluate the efficacy of anti-vascular endothelial growth factor (VEGF) compared with observation for treating acute central serous chorioretinopathy (CSC). METHODS: A retrospective study of 36 patients with acute CSC, including 21 patients treated with anti-VEGF (anti-VEGF group) and 15...
Autores principales: | Park, Sang-Uk, Lee, Seung-Jun, Kim, Moosang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120351/ https://www.ncbi.nlm.nih.gov/pubmed/25120339 http://dx.doi.org/10.3341/kjo.2014.28.4.306 |
Ejemplares similares
-
Central Serous Chorioretinopathy Following Intravitreal Dexamethasone Implant
por: Noh, Gwang Myeong, et al.
Publicado: (2019) -
Traumatic central serous chorioretinopathy in the fellow eye
por: Yu, Seung-Young, et al.
Publicado: (2016) -
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016) -
The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy
por: Maleki, Alireza, et al.
Publicado: (2018) -
The Efficacy of Intravitreal Conbercept for Chronic Central Serous Chorioretinopathy
por: Mao, Jianbo, et al.
Publicado: (2019)